Coherus Rolls Out YUSIMRY At $995 Per Carton In US

RTTNews | vor 850 Tagen
Coherus Rolls Out YUSIMRY At $995 Per Carton In US

(RTTNews) - Coherus BioSciences, Inc. (CHRS) announced Monday that YUSIMRY (adalimumab-aqvh) is now available for commercial sale in the United States at a list price of $995 per carton for two 40 mg/0.8 mL autoinjectors.

The pricing represents a discount of more than 85% to Humira (adalimumab), currently priced at $6,922 per carton of two pens.

YUSIMRY is presented in a state-of-the-art autoinjector and includes Coherus' proprietary non-stinging, citrate-free formulation and a 29-gauge needle.

YUSIMRY, approved in 2021 by the U.S. Food and Drug Administration, is a tumor necrosis factor blocker indicated to reduce the signs and symptoms of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, and ankylosing spondylitis, and to treat Crohn's disease, ulcerative colitis, plaque psoriasis and hidradenitis suppurativa.

YUSIMRY Solutions - Coherus' patient services platform - will ensure improved access and a fast and seamless experience as patients start or switch to YUSIMRY treatment based on a determination by their healthcare provider.

read more
Coherus, Junshi Biosciences Say FDA Accepts Resubmission Of Toripalimab BLA

Coherus, Junshi Biosciences Say FDA Accepts Resubmission Of Toripalimab BLA

Coherus BioSciences, Inc. (CHRS) and Shanghai Junshi Biosciences Co., Ltd. announced Wednesday that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) resubmission for toripalimab in combination with gemcitabine and cisplatin as first-line treatment for patients with advanced recurrent or metastatic nasopharyngeal carcinoma (NPC) and for toripalimab monotherapy for the second-line or later treatment of recurrent or metastatic NPC after platinum-containing chemotherapy.
RTTNews | vor 1213 Tagen
Japan Industrial Output Rebounds; Tokyo Inflation Accelerates

Japan Industrial Output Rebounds; Tokyo Inflation Accelerates

Japan's industrial production rebounded at a stronger-than-expected pace at the end of the third quarter and inflation in Tokyo accelerated further in October, official data revealed Friday. Industrial output advanced 2.2 percent month-on-month, in contrast to the 1.5 percent drop in August, the Ministry of Economy, Trade and Industry said. Output was forecast to grow moderately by 1.5 percent.
RTTNews | vor 1Std 41 Minuten
European Shares Seen Tad Lower At Open

European Shares Seen Tad Lower At Open

European markets may open slightly lower on Friday, although tech stocks may rise following strong earnings from e-commerce giant Amazon and iPhone maker Apple.
RTTNews | vor 2Std 50 Minuten
NZ Dollar Falls Against Majors

NZ Dollar Falls Against Majors

The New Zealand dollar weakened against other major currencies in the Asian session on Friday.
RTTNews | vor 2Std 53 Minuten
European Economic News Preview: Eurozone Flash Inflation Data Due

European Economic News Preview: Eurozone Flash Inflation Data Due

Flash inflation from the euro area and France are the top economic news due on Friday, headlining a busy day for the European economic news. At 3.00 am ET, Destatis is scheduled to issue Germany's retail sales and import prices. Sales are forecast to grow 0.2 percent month-on-month, reversing a 0.2 percent fall in August. Economists expect import prices to drop 0.2 percent.
RTTNews | vor 3Std 7 Minuten
Sensex, Nifty Modestly Higher In Early Trade

Sensex, Nifty Modestly Higher In Early Trade

Indian shares were slightly higher on Friday despite mixed cues from global markets. The benchmark BSE Sensex was up 180 points, or 0.2 percent, at 84,583 in early trade, while the broader NSE Nifty index edged up by 38 points, or 0.2 percent, to 25,915.
RTTNews | vor 4Std 3 Minuten
Australian Market Trims Early Gains In Mid-market

Australian Market Trims Early Gains In Mid-market

The Australian stock market is trimming its early gains in mid-market moves on Friday, snapping a three-session losing streak, despite the broadly negative cues from Wall Street overnight. The benchmark S&P/ASX 200 is moving above the 8,900 level, with strong gains in gold miner stocks partially offset by weakness in technology stocks.
RTTNews | vor 5Std 2 Minuten